tiprankstipranks
Trending News
More News >
Hyloris Pharmaceuticals SA (DE:52U)
FRANKFURT:52U
Germany Market

Hyloris Pharmaceuticals SA (52U) Financial Statements

Compare
7 Followers

Hyloris Pharmaceuticals SA Financial Overview

Hyloris Pharmaceuticals SA's market cap is currently €224.00M. The company's EPS TTM is €-0.127; its P/E ratio is -32.14; Hyloris Pharmaceuticals SA is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 10.04M€ 2.09M€ 2.95M€ 3.10M€ 175.00K
Gross Profit€ 9.81M€ 1.99M€ 2.86M€ 2.99M€ 30.00K
Operating Income€ -7.13M€ -15.99M€ -11.64M€ -4.94M€ -7.03M
EBITDA€ -4.85M€ -14.98M€ -11.43M€ -10.78M€ -6.17M
Net Income€ -6.34M€ -15.38M€ -11.91M€ -11.58M€ -7.15M
Balance Sheet
Cash & Short-Term Investments€ 24.15M€ 30.41M€ 43.46M€ 50.54M€ 64.41M
Total Assets€ 41.34M€ 47.68M€ 61.86M€ 63.44M€ 69.18M
Total Debt€ 1.81M€ 1.75M€ 885.00K€ 12.29M€ 8.45M
Net Debt€ -21.78M€ -28.66M€ -42.57M€ -37.72M€ -55.95M
Total Liabilities€ 9.19M€ 8.61M€ 6.82M€ 15.39M€ 10.12M
Stockholders' Equity€ 32.14M€ 39.07M€ 53.91M€ 48.06M€ 59.06M
Cash Flow
Free Cash Flow€ -6.73M€ -13.11M€ -13.89M€ -12.31M€ -5.19M
Operating Cash Flow€ -6.70M€ -12.81M€ -13.15M€ -11.25M€ -4.57M
Investing Cash Flow€ 259.00K€ 9.89M€ -1.24M€ -3.08M€ -633.00K
Financing Cash Flow€ -368.00K€ -131.00K€ 7.84M€ -62.00K€ 69.40M
Currency in EUR

Hyloris Pharmaceuticals SA Earnings and Revenue History

Hyloris Pharmaceuticals SA Debt to Assets

Hyloris Pharmaceuticals SA Cash Flow

Hyloris Pharmaceuticals SA Forecast EPS vs Actual EPS